Safety and Immunogenicity of the PRAME Cancer Immunotherapeutic in Patients with Resected Non–Small Cell Lung Cancer: A Phase I Dose Escalation Study
Pujol, Jean-Louis, De Pas, Tommaso, Rittmeyer, Achim, Vallières, Eric, Kubisa, Bartosz, Levchenko, Eugeny, Wiesemann, Sebastian, Masters, Gregory A., Shen, Robert, Tjulandin, Sergei A., Hofmann, Hans-Stefan, Vanhoutte, Nicolas, Salaun, Bruno, Debois, Muriel, Jarnjak, Silvija, De Sousa Alves, Pedro Miguel, Louahed, Jamila, Brichard, Vincent G. and Lehmann, Frédéric F. (2016) Safety and Immunogenicity of the PRAME Cancer Immunotherapeutic in Patients with Resected Non–Small Cell Lung Cancer: A Phase I Dose Escalation Study. Journal of Thoracic Oncology 11 (12), pp. 2208-2217.Date of publication of this fulltext: 17 Mar 2020 12:05
Article
Alternative links to fulltext
Involved Institutions
Details
| Item type | Article | ||||
| Journal or Publication Title | Journal of Thoracic Oncology | ||||
| Volume: | 11 | ||||
|---|---|---|---|---|---|
| Number of Issue or Book Chapter: | 12 | ||||
| Page Range: | pp. 2208-2217 | ||||
| Date | 2016 | ||||
| Institutions | UNSPECIFIED | ||||
| Identification Number |
| ||||
| Dewey Decimal Classification | UNSPECIFIED | ||||
| Status | Published | ||||
| Refereed | Yes, this version has been refereed | ||||
| Created at the University of Regensburg | Yes | ||||
| Item ID | 42764 |
Export bibliographical data
Owner only: item control page
Altmetric
Altmetric